Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

ClinicalTrials.gov ID: NCT06360380

Public ClinicalTrials.gov record NCT06360380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

REFORM-HF™ Reducing Fluid Overload Using Renal Independent systeM in Heart Failure Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps remove excess fluids through their sweat. The investigators want to see if the AQUAPASS system can remove an additional 500mL of fluids during treatment, alongside patients' regular medications like diuretics. Participants will be treated in the hospital or in the outpatient clinic.

Study identification

NCT ID
NCT06360380
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
AquaPass Medical Ltd.
Industry
Enrollment
40 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
21 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2024
Primary completion
Jul 31, 2026
Completion
Mar 31, 2027
Last update posted
Jul 5, 2026

2024 – 2027

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
UC San Diego Health-Sulpizio Cardiovascular Center La Jolla California 92037 Recruiting
UC San Francisco San Francisco California 94143 Recruiting
University of Minnesota Minneapolis Minnesota 55455 Recruiting
Northwell Health- Lenox Hill Hospital New York New York 10075 Recruiting
Rochester Regional Health Rochester New York 14621 Recruiting
Mission Hospital Asheville North Carolina 28801 Recruiting
Cone Health Advanced Heart Failure Clinic at Moses Cone Greensboro North Carolina 27401 Recruiting
Austin Heart Hospital Austin Texas 78705 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06360380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06360380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →